Combined epidemiological and genomic analysis of nosocomial SARS-CoV-2 infection early in the pandemic and the role of unidentified cases in transmission.

Healthcare-associated infection Molecular epidemiology Nosocomial transmission SARS-CoV-2 Whole-genome sequencing

Journal

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
ISSN: 1469-0691
Titre abrégé: Clin Microbiol Infect
Pays: England
ID NLM: 9516420

Informations de publication

Date de publication:
Jan 2022
Historique:
received: 03 05 2021
revised: 28 07 2021
accepted: 31 07 2021
pubmed: 18 8 2021
medline: 6 1 2022
entrez: 17 8 2021
Statut: ppublish

Résumé

To analyse nosocomial transmission in the early stages of the coronavirus 2019 (COVID-19) pandemic at a large multisite healthcare institution. Nosocomial incidence is linked with infection control interventions. Viral genome sequence and epidemiological data were analysed for 574 consecutive patients, including 86 nosocomial cases, with a positive PCR test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during the first 19 days of the pandemic. Forty-four putative transmission clusters were found through epidemiological analysis; these included 234 cases and all 86 nosocomial cases. SARS-CoV-2 genome sequences were obtained from 168/234 (72%) of these cases in epidemiological clusters, including 77/86 nosocomial cases (90%). Only 75/168 (45%) of epidemiologically linked, sequenced cases were not refuted by applying genomic data, creating 14 final clusters accounting for 59/77 sequenced nosocomial cases (77%). Viral haplotypes from these clusters were enriched 1-14x (median 4x) compared to the community. Three factors implicated unidentified cases in transmission: (a) community-onset or indeterminate cases were absent in 7/14 clusters (50%), (b) four clusters (29%) had additional evidence of cryptic transmission, and (c) in three clusters (21%) diagnosis of the earliest case was delayed, which may have facilitated transmission. Nosocomial cases decreased to low levels (0-2 per day) despite continuing high numbers of admissions of community-onset SARS-CoV-2 cases (40-50 per day) and before the impact of introducing universal face masks and banning hospital visitors. Genomics was necessary to accurately resolve transmission clusters. Our data support unidentified cases-such as healthcare workers or asymptomatic patients-as important vectors of transmission. Evidence is needed to ascertain whether routine screening increases case ascertainment and limits nosocomial transmission.

Identifiants

pubmed: 34400345
pii: S1198-743X(21)00435-3
doi: 10.1016/j.cmi.2021.07.040
pmc: PMC8361005
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

93-100

Subventions

Organisme : Medical Research Council
ID : MC_PC_15068
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_19027
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_U117562207
Pays : United Kingdom

Informations de copyright

Copyright © 2021. Published by Elsevier Ltd.

Références

JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
Infect Control Hosp Epidemiol. 2020 Jul;41(7):866-867
pubmed: 32223768
Elife. 2021 Jun 29;10:
pubmed: 34184637
J Hosp Infect. 2020 Oct;106(2):376-384
pubmed: 32702463
Jpn J Infect Dis. 2020 Nov 24;73(6):399-403
pubmed: 32475877
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
BMJ Open. 2020 Aug 16;10(8):e039652
pubmed: 32801208
Infect Genet Evol. 2020 Sep;83:104351
pubmed: 32387564
JAMA. 2020 Aug 25;324(8):782-793
pubmed: 32648899
Clin Infect Dis. 2021 Feb 16;72(4):690-693
pubmed: 32562422
J Epidemiol Community Health. 2021 Feb;75(2):185-188
pubmed: 33004659
Nat Med. 2020 Sep;26(9):1398-1404
pubmed: 32647358
Genome Biol. 2021 Jul 1;22(1):196
pubmed: 34210356
Nat Microbiol. 2020 Dec;5(12):1598-1607
pubmed: 33106674
Clin Infect Dis. 2021 Jun 1;72(11):e727-e735
pubmed: 32954414
Ann Intern Med. 2020 May 05;172(9):577-582
pubmed: 32150748
Lancet Infect Dis. 2020 Nov;20(11):1263-1272
pubmed: 32679081
J Hosp Infect. 2020 Nov;106(3):621-625
pubmed: 32841703
Eur J Psychiatry. 2020 Jul-Sep;34(3):177-179
pubmed: 32313348
Euro Surveill. 2020 Aug;25(32):
pubmed: 32794447

Auteurs

Luke B Snell (LB)

Centre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, UK; Directorate of Infection, Guy's and St Thomas' NHS Foundation Trust, London, UK.

Chloe L Fisher (CL)

Genomics Innovation Unit, Guy's and St Thomas' NHS Foundation Trust, London, UK.

Usman Taj (U)

Directorate of Infection, Guy's and St Thomas' NHS Foundation Trust, London, UK.

Oliver Stirrup (O)

University College London, Gower St, London, UK.

Blair Merrick (B)

Centre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, UK; Directorate of Infection, Guy's and St Thomas' NHS Foundation Trust, London, UK.

Adela Alcolea-Medina (A)

Infection Sciences, Viapath, St Thomas' Hospital, London, UK.

Themoula Charalampous (T)

Centre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, UK.

Adrian W Signell (AW)

University College London, Gower St, London, UK.

Harry D Wilson (HD)

Department of Infectious Diseases, School of Immunological and Microbial Sciences, King's College London, UK.

Gilberto Betancor (G)

Department of Infectious Diseases, School of Immunological and Microbial Sciences, King's College London, UK.

Mark Tan Kia Ik (MT)

Centre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, UK.

Emma Cunningham (E)

Infection Sciences, Viapath, St Thomas' Hospital, London, UK.

Penelope R Cliff (PR)

Infection Sciences, Viapath, St Thomas' Hospital, London, UK.

Suzanne Pickering (S)

Department of Infectious Diseases, School of Immunological and Microbial Sciences, King's College London, UK.

Rui Pedro Galao (RP)

Department of Infectious Diseases, School of Immunological and Microbial Sciences, King's College London, UK.

Rahul Batra (R)

Centre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, UK; Directorate of Infection, Guy's and St Thomas' NHS Foundation Trust, London, UK.

Stuart J D Neil (SJD)

Department of Infectious Diseases, School of Immunological and Microbial Sciences, King's College London, UK.

Michael H Malim (MH)

Department of Infectious Diseases, School of Immunological and Microbial Sciences, King's College London, UK.

Katie J Doores (KJ)

Department of Infectious Diseases, School of Immunological and Microbial Sciences, King's College London, UK.

Sam T Douthwaite (ST)

Directorate of Infection, Guy's and St Thomas' NHS Foundation Trust, London, UK.

Gaia Nebbia (G)

Centre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, UK; Directorate of Infection, Guy's and St Thomas' NHS Foundation Trust, London, UK.

Jonathan D Edgeworth (JD)

Centre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, UK; Directorate of Infection, Guy's and St Thomas' NHS Foundation Trust, London, UK.

Ali R Awan (AR)

Genomics Innovation Unit, Guy's and St Thomas' NHS Foundation Trust, London, UK. Electronic address: ali.awan@kcl.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH